Wave Life Sciences (WVE) Assets Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.73% |
| Dec 31, 2025 | 63.39% |
| Sep 30, 2025 | 9.97% |
| Jun 30, 2025 | 5.76% |
| Mar 31, 2025 | 19.88% |
| Dec 31, 2024 | 19.38% |
| Sep 30, 2024 | 21.37% |
| Jun 30, 2024 | 0.39% |
| Mar 31, 2024 | -1.02% |
| Dec 31, 2023 | -0.51% |
| Sep 30, 2023 | -13.61% |
| Jun 30, 2023 | 4.09% |
| Mar 31, 2023 | 3.86% |
| Dec 31, 2022 | -19.84% |
| Sep 30, 2022 | -19.44% |
| Jun 30, 2022 | -17.90% |
| Mar 31, 2022 | -27.02% |
| Dec 31, 2021 | -11.23% |
| Sep 30, 2021 | -14.83% |
| Jun 30, 2021 | -16.44% |
| Mar 31, 2021 | 17.28% |
| Dec 31, 2020 | 15.37% |
| Sep 30, 2020 | 15.34% |
| Jun 30, 2020 | -3.43% |
| Mar 31, 2020 | 16.34% |
| Dec 31, 2019 | 19.92% |
| Sep 30, 2019 | 24.49% |
| Jun 30, 2019 | 26.53% |
| Mar 31, 2019 | 39.53% |
| Dec 31, 2018 | 21.40% |
| Sep 30, 2018 | 65.97% |
| Dec 31, 2017 | 295.56% |